SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies (ROLR) is trending with extreme volatility following its exclusive partnership with crypto.com/us to launch event-based prediction markets in the United States, targeting a market with substantial growth potential. The trading community is actively discussing multiple halts and the possibility of a significant short squeeze, drawing parallels to previous parabolic stock movements.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to significant high-grade rare earth element drilling results from its Tanbreez project, which confirm strategic metals crucial for Western supply chains. The market is also heavily anticipating outcomes from high-level meetings between U.S., Danish, and Greenlandic officials regarding potential U.S. involvement in Greenland's critical mineral resources. This confluence of positive exploration news and strategic geopolitical interest is driving widespread community discussion and strong conviction among investors despite recent volatility.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as investor interest intensifies around the critical role of photonics and optical interconnects in next-generation AI and data center infrastructure, following recent industry discussions on co-packaged optics. The community is highly optimistic about POET's patented Optical Interposer technology, viewing it as a game-changer for efficient, high-volume production of optical engines that address bottlenecks in AI computing. Many anticipate imminent news regarding substantial production orders or partnerships with major industry players, despite ongoing market dynamics influenced by upcoming options expiry and perceived price manipulation.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy (MSTR) is trending, driven by active discussion around its direct correlation to Bitcoin's price fluctuations. The community is closely watching CEO Michael Saylor's ongoing At-The-Market offering, with debates balancing concerns over potential dilution against expectations for a significant short squeeze. Many investors remain bullish, seeing MSTR's strategic Bitcoin holdings as a key factor for future upside.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

CleanSpark is trending due to its strategic expansion into AI and high-performance computing data centers, marked by a significant land and power acquisition in Texas. This pivot, alongside ongoing Bitcoin mining operations and recent analyst upgrades, is driving strong bullish sentiment and predictions of a re-rating, though some community members express skepticism about the immediate monetization of its AI infrastructure. The company's performance is closely watched for its ability to secure major AI compute contracts and capitalize on Bitcoin's market movements.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity is trending amid a wave of analyst upgrades, citing its strengthening mobile advertising platform and the growth potential of new commerce tools within the broader real-time 3D development space. The community is actively discussing a potential breakout beyond previous resistance levels, with many viewing recent dips as buying opportunities while others remain cautious given historical volatility. Optimism is fueled by the performance of its Vector AI platform and strategic partnerships, indicating confidence in its long-term trajectory across gaming, digital twins, and AI applications.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin (APP) is experiencing significant volatility, marked by a notable price decline occurring despite recent bullish analyst upgrades that highlight its AI-powered AXON platform and expanding e-commerce advertising initiatives. The community is sharply divided, with many actively buying the dip and attributing the downturn to market manipulation or broader tech sector weakness, while others express concerns about overvaluation and potential further correction. The stock's characteristic swings keep traders engaged, debating its strategic position in the evolving ad-tech landscape.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics (TGTX) is generating significant discussion after reporting strong preliminary Q4 and FY2025 revenue for its MS drug BRIUMVI, alongside optimistic 2026 guidance. Despite this robust commercial execution, the community is intensely debating the stock's "undervalued" status and persistent "manipulation" by shorts, while many anticipate a potential acquisition or substantial upside from BRIUMVI's "best-in-class" profile and upcoming SubQ formulation.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending due to significant buzz at the J.P. Morgan Healthcare Conference, bolstered by the recent publication of strong Phase 2 data for its obesity drug, VK2735. The community is actively discussing heightened speculation around a potential major partnership or acquisition, particularly after a peer CEO's recent comments on substantial M&A spending. This has intensified debates over the company's valuation and its "best-in-class" assets in the competitive weight-loss market.

New Century Logistics (BVI) Ltd. is a holding company, which is doing business through its subsidiaries, providing air and ocean export and import freight forwarding & logistics services. It offers cargo space, cargo pick up, off-airport air cargo security screening, palletization, preparation of shipping documentation, arrangement of customs clearance to cargo handling at ports and other related services. The company was founded on April 24, 2019 and is headquartered in Hong Kong.

New Century Logistics (BVI) Ltd.

New Century Logistics

New Century Logistics (NCEW) is generating significant buzz due to its extremely low share float and recent strategic announcements, including an acquisition in Asia and a partnership for drone-based last-mile delivery. The community is actively discussing its potential for a massive short squeeze, drawing comparisons to other "Hong Kong low float" stocks that have seen explosive gains. This combination positions NCEW as a speculative high-volatility play within the logistics sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$NVCT big pharma isn’t sitting still yet I’m always seeing huge valuation metrics around NXP900. New 1L drugs with better efficacy complicate the NVCT combo therapy story around NSCLC resistance 

https://www.ajmc.com/view/weighing-osimertinib-vs-amivantamab-lazertinib-in-frontline-egfr-nsclc-danny-nguyen-md

Amivantamab plus lazertinib enhances survival in NSCLC but requires complex care compared with osimertinib, explained Danny Nguyen, MD, of City of Hope.

Ajmc

Weighing Osimertinib vs Amivantamab-Lazertinib in Frontline EGFR NSCLC: Danny Nguyen, MD | AJMC

StockTwits for iOS

Nuvectis Pharma Inc

 big pharma isn’t sitting still yet I’m always seeing huge valuation metrics around NXP900. New 1L drugs with better efficacy complicate the NVCT combo therapy story around NSCLC resistance 



Verastem Inc

Axsome Therapeutics Inc

Gossamer Bio Inc

Opendoor Technologies Inc

Immuneering Corp

MoonLake Immunotherapeutics

Q/C Technologies Inc.

Dalvin Varnado

@UNLV management is slow. Number of companies have moved their drugs faster than this management. Listen to all the NUVL, RVMD, BBOT calls. These guys move 3-4x faster than the nvct team. Hopefully, going forward they can execute faster with 800 distractions behind.

 management is slow. Number of companies have moved their drugs faster than this management. Listen to all the NUVL, RVMD, BBOT calls. These guys move 3-4x faster than the nvct team. Hopefully, going forward they can execute faster with 800 distractions behind.

Avidity Biosciences Inc

Syndax Pharmaceuticals Inc

aTyr Pharma, Inc

Trader2

@BioTrade2 those companies more employees and date back prior decade. NVCT with 13 employees and tiny research team did preclinical data and predictive bio markers to a multiple of different tumors in a few years leading into 1b. With @biospeculator contemplating 10B valuation can’t imagine your comparisons

 those companies more employees and date back prior decade. NVCT with 13 employees and tiny research team did preclinical data and predictive bio markers to a multiple of different tumors in a few years leading into 1b. With 

 contemplating 10B valuation can’t imagine your comparisons

@BioTrade2 @biospeculator beyond extremely low cost structure of 13 employees holders of NVCT stock aren’t facing major dilutions around stock option compensation. RVMD a 15B mc but IPO investors have only 5x returns. NUVL a 8B mc with IPO investors 6x returns. Both stocks IPO at $17 and I’m thinking higher returns for NVCT if drugs goes phase 3 upon high expectations

 beyond extremely low cost structure of 13 employees holders of NVCT stock aren’t facing major dilutions around stock option compensation. RVMD a 15B mc but IPO investors have only 5x returns. NUVL a 8B mc with IPO investors 6x returns. Both stocks IPO at $17 and I’m thinking higher returns for NVCT if drugs goes phase 3 upon high expectations